Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825766 | Clinical Therapeutics | 2012 | 17 Pages |
Abstract
Oral mirabegron exhibited a greater-than-dose-proportional increase in exposure. Sex but not age significantly affected mirabegron exposure. ClinicalTrials.gov identifier: NCT01478503 (Study 1) and NCT01285596 (Study 2).
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Walter MSc, Jan BSc, Marloes PhD, Charlotte MSc, John MSc, Grégory MD, Sjoerd MD, Virginie PhD, Marcel PhD,